search
Back to results

Optical Coherence Tomography in the Diagnosis of Scleritis and Episcleritis

Primary Purpose

Scleritis and Episcleritis

Status
Completed
Phase
Not Applicable
Locations
Saudi Arabia
Study Type
Interventional
Intervention
Optical Coherence Tomography
Sponsored by
The Eye Center and The Eye Foundation for Research in Ophthalmology
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional diagnostic trial for Scleritis and Episcleritis focused on measuring Scleritis, Episcleritis, Optical coherence Tomography

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Patients over the age of 18 years any gender
  • Patients with clinical signs of scleritis or episcleritis
  • Signed informed consent

Exclusion Criteria:

  • Infectious keratitis or conjunctivitis
  • Patients 18 years or younger
  • Inability to open the eye

Sites / Locations

  • The Eye Center

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Experimental

Arm Label

Patients with clinical signs of scleritis or episcleritis

Normal subjects with normal sclera

Arm Description

Optical Coherence Tomography for patients with scleral inflammation

Optical Coherence Tomography on eyes with normal scleral

Outcomes

Primary Outcome Measures

To describe the optical coherence tomography (OCT) findings in eyes with scleral inflammation
To differentiate cases with anterior scleritis from those with episcleritis and normal controls

Secondary Outcome Measures

Full Information

First Posted
October 7, 2013
Last Updated
August 29, 2014
Sponsor
The Eye Center and The Eye Foundation for Research in Ophthalmology
search

1. Study Identification

Unique Protocol Identification Number
NCT01958567
Brief Title
Optical Coherence Tomography in the Diagnosis of Scleritis and Episcleritis
Official Title
Optical Coherence Tomography in the Diagnosis of Scleritis and Episcleritis
Study Type
Interventional

2. Study Status

Record Verification Date
August 2014
Overall Recruitment Status
Completed
Study Start Date
July 2012 (undefined)
Primary Completion Date
April 2014 (Actual)
Study Completion Date
April 2014 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
The Eye Center and The Eye Foundation for Research in Ophthalmology

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
The main purpose of this study is to describe the optical coherence tomography (OCT) findings in eyes with scleral inflammation and to differentiate cases with anterior scleritis from those with episcleritis and normal controls.
Detailed Description
A total of 40 eyes will be included. 20 eyes with scleral inflammation and 20 eyes from healthy subjects as controls. Each patient will undergo complete ophthalmic and medical examination. Laboratory studies will performed whenever indicated. Optical coherence tomography B-scans of the sclera in the perilimbal area will done for all cases.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Scleritis and Episcleritis
Keywords
Scleritis, Episcleritis, Optical coherence Tomography

7. Study Design

Primary Purpose
Diagnostic
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Non-Randomized
Enrollment
32 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Patients with clinical signs of scleritis or episcleritis
Arm Type
Experimental
Arm Description
Optical Coherence Tomography for patients with scleral inflammation
Arm Title
Normal subjects with normal sclera
Arm Type
Experimental
Arm Description
Optical Coherence Tomography on eyes with normal scleral
Intervention Type
Other
Intervention Name(s)
Optical Coherence Tomography
Primary Outcome Measure Information:
Title
To describe the optical coherence tomography (OCT) findings in eyes with scleral inflammation
Description
To differentiate cases with anterior scleritis from those with episcleritis and normal controls
Time Frame
3 months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Patients over the age of 18 years any gender Patients with clinical signs of scleritis or episcleritis Signed informed consent Exclusion Criteria: Infectious keratitis or conjunctivitis Patients 18 years or younger Inability to open the eye
Facility Information:
Facility Name
The Eye Center
City
Riyadh
Country
Saudi Arabia

12. IPD Sharing Statement

Learn more about this trial

Optical Coherence Tomography in the Diagnosis of Scleritis and Episcleritis

We'll reach out to this number within 24 hrs